AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sulnox Group PLC

Regulatory Filings Nov 3, 2020

10293_rns_2020-11-03_70f18924-23eb-481c-9ef1-cf8e3c368c92.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0186E

SulNOx Group PLC

03 November 2020

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.  The directors take responsibility for this announcement.

3 November 2020

SulNOx Group Plc (the "Company" or "SulNOx")

Company Update

(Aquis Stock Exchange: SNOX)

The Company provides an update to its shareholders as follows.

Trading Update

With the uncertainty surrounding the future management, strategy, direction, financial position, and board structure of the Company following:

1.    the requisition of a general meeting to change the board of directors, as announced on 16 October 2020 (the "GM"); and

2.   the results of voting on various resolution at the Company's annual general meeting (the "AGM"), as announced on 23 October 2020.

The current directors of the Company (the "Directors"), details of whom can be found in the section below, have concluded that the most prudent actions are, where possible:

1.    to avoid entering into any new contracts;

2.    to suspend or terminate any existing contracts;

3.    to settle amounts owed under existing contracts; and

4.    to seek professional advice as to their obligations under the Companies Act 2006 (the "Act") and other appropriate UK legislation.

Following the commencement of these actions, the Company and its operating subsidiaries now have minimal cash balances and the Directors have requested confirmation of future financial support from the requisitioners of the GM, whose details are set out in the announcement of 16 October 2020 (the "Requisitioners").   The Directors believe that the Company will not be able to continue trading without the agreement of the Requisitioners to introduce more funds. The notice calling the GM is required to be sent out this week in accordance with the requirements of the Act, however due to the Company's current financial position, a request has been made to the Requisitioners to advance the costs associated with the GM, some of which have already been made.

Directors

As set out in the announcement of 23 October 2020, the board of directors of the Company now consists of Nicholas Nelson and Simon Retter.  The employment contracts of both Mr Nelson (previously Chief Executive Officer) and Mr Retter (previously Finance Director) have been terminated, however they remain statutory directors in accordance with the Act, which requires a public limited company to have at least two directors.  Mr Nelson also remains as Company Secretary.

Suspension of Trading on AQSE Growth Market

Trading of the Company's ordinary shares of 2 pence each ("Ordinary Shares") will remain suspended from trading on the AQSE Growth Market for the reasons set out in the announcement of 23 October 2020.

The Company will make a further update shortly.

Enquiries:

SulNOx Group Plc

Nicholas Nelson, Chief Executive
[email protected]
Media and Investors:

Flagstaff Strategic and Investor Communications

Tim Thompson / Fergus Mellon
[email protected]

020 7129 1474
AQSE Corporate Adviser:

Allenby Capital Limited

John Depasquale / Nick Harriss / James Hornigold
020 3328 5656

The directors take responsibility for this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXBTBBTMTJMTAM

Talk to a Data Expert

Have a question? We'll get back to you promptly.